Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Activist Investor Urges Amgen To Break Up

Job Cuts Loom Over GlaxoSmithKline As It Aims To Cut Costs; Eyes IPO Of HIV Unit

GlaxoSmithKline's Rising Star Under Pressure As Drugs Falter

Roche To Spend $3.2 Billion On Basel Site Upgrade

What Happens When Chemists Don't Wash Their Hands

Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study

Johnson & Johnson Pledges $200 Million To Ebola, Will Begin Testing Vaccine In January 2015

Woman Finds Three-Inch Leech In Nose After South East Asia Trip

Shift Workers Might Want To Skip High-Iron Foods At Night, University of Utah Study

GlaxoSmithKline, Johnson & Johnson Join Forces To Make Millions Of Ebola Vaccine Doses

Recalled Dietary Supplements Found To Still Contain Banned Substances

Walnuts May Help Protect Against Alzheimer???s Disease, Reveals

Flu Vaccine May Hold Key To Preventing Heart Disease, Study

Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form

Vertex Pharmaceuticals (MA) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion

Actavis Pays $40 Million Upfront; Snags Option To Buy

Lexicon Pharmaceuticals, Inc., Ipsen Strike Licensing Deal Worth $145 Million

Boston's Proteon Therapeutics, Inc. Files For $61 Million IPO

Sucampo Pharmaceuticals, Inc., Takeda Forge $55 Million Deal For Amitiza®

AcelRx Pharmaceuticals's Zalviso Met Primary Endpoint In Phase 3 Study

Gilead Sciences, Inc.'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons

Should We Allow Scientists To Create Super-Viruses?

Gilead Sciences, Inc. To Create More Than 80 Jobs With $50 Million Expansion

For Infertility Treatment, Should He Drink Less Coffee, More Booze? Harvard School of Public Health Study

Parkinson???s Drugs Linked To Impulse Control Disorders, Study

Cold Sore Virus Increases The Risk Of Dementia, Umea University Study

Actavis Will Compete With Sanofi For $5.1 Billion Omega Pharma NV Deal

Panic Attacks Associated With Fear Of Bright Daylight, University of Siena Study

Viamet Pharmaceuticals Reels In $60 Million Series D Financing

Brain Scans Show Cause Of Seasonal Affective Disorder, University of Copenhagen Study

FDA Panel Unanimously Backs Novartis AG' Psoriasis Drug

Vericel, An Old Genzyme Corporation Business, Quietly Gets New Life And Space In Cambridge

Number Of Eggs A Woman Has Predicts Heart Attack Risk, University of California, San Francisco (UCSF) Study

Omeros Corporation Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday

Celgene???s New Crohn???s Disease Drug Impressing Analysts

Aspirin Shown To Benefit Schizophrenia Treatment, University Medical Center Utrecht Study

New Biotech, Launches In Cambridge With $12 Million In Pocket

ISI Group: AbbVie???s Dividend, Repurchasing Attempt Could Mean More Debt

Biotech Startup Factory PureTech Nabs $55 Million

Valeant Hints At Higher Bid For Allergan Inc.

AbbVie Officially Abandons

Analysts Predict FDA Approval Of Novo Nordisk A/S's Obesity Drug By Year-End

Despite Conflicting Data, Cytokinetics, Inc. Plans To Take ALS Drug Into Late Stage Study

GlycoMimetics, Inc. Signs A Long Term Lease For A Bigger Space In Maryland

Lupin Ltd. Scouts For Acquisitions In U.S.

Enanta Pharmaceuticals, Inc. Rejects HCV Drug Co-Development Option With AbbVie

Rho Awarded New Federal Contract From

David And Barbara Roux Provide Historic $10 Million Gift To Advance Genomic Medicine Research At The Jackson Laboratory

Fab'entech: Committed To Fight Emerging Infectious Diseases

AstraZeneca PLC, Bristol-Myers Squibb Company Won???t Have To Face Kickback Lawsuit

Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC

Current Climate The Best For Biotech IPOs In Decades, Says VC

Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist

Ebola Clinical Trials: Big Name Players In The Ebola Race

Genentech, NewLink Genetics Strike $1 Billion+ Cancer Deal

Don't Blame CDC Chief For Ebola

Big Pharma Has An Interest In Rich People Being Sick

Allergan Inc. Chops Jobs In Carlsbad

Shire Goes Shopping After AbbVie Deal Falls Through

Shire's Finance Chief Jumps Ship

Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences In Deal Worth $305 Million

Amgen Will Assign 12 To 14 Staff Members To Look Into An Alternative Production Method For Mapp Biopharmaceutical's ZMapp

TesoRx, Ink $95 Million Pact

Cubist Pharmaceuticals, Inc. Brings In Ex-Biogen Idec Exec For CEO Post

Regeneron's EYLEA?? Tops Rivals In Study

Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study

Xenon Pharmaceuticals Inc. Postpones IPO

Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout

Fresenius AG, Buyout Groups Eye Medical Nutrition Unit

Redag Crop Protection To Create 20 R&D Jobs

Birth Season Affects Your Mood In Later Life, Semmelweis University Study

Regeneron, Sanofi Begin Pivotal Phase 3 Study For Eczema Drug Dupilumab

Neothetics Files To Raise $63 Million To Fight Fat With An Asthma Drug

Exelixis, Inc. To Vacate Most Of Its South San Francisco Office Space

Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO

BaseHealth Names Former Illumina, Inc. Executive Jorge Velarde As New CEO And President

Therapix Names CEO

As Apple, Offer Egg Freezing, Debate Swirls

Novartis AG's Leukemia Drug CTL01 Clears Cancer In 90 Percent Of Patients

U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans

Oh, Brother! Having A Sibling Makes Boys Selfless, Brigham Young University Study

Why Depression And Aging Boost Disease Risk, Reveals

Honeysuckle Tea Can Treat Influenza A Viruses, And Possibly Ebola, Study

How Omega-6 Fatty Acids Lower Bad Cholesterol, Innsbruck Medical University Study

Are Male Brains Wired To Ignore Food For Sex? University of Rochester Medical Center Study

Drinking Red Wine May Help Treat Osteoporosis, Aarhus University Study

Here???s What An AbbVie-Split Might Mean For Massachusetts

Roche, Merck & Co. Extend Immunotherapy Battle To Breast Cancer

Canaan Closes $675 Million Fund With An Eye For Biotech And Medtech Startups

Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond

Lawyers Have Documents That Prove Allergan Inc. Misled Investors About Valeant:

AbbVie Board Officially Abandons $55 Billion Merger

Repros Therapeutics Inc. Shares Tank On Drug Application Setback

Can This One Man And His Tiny Biotech Stop Ebola?

Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2%

Novartis AG Psoriasis Drug Secukinumab Benefits Outweighs Risk: FDA Staff

AbbVie Still A Buy Despite Shire Fallout, Says Analyst

Cowen and Company: Best Buys, Favorable Biotech Outlook Remain

Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc.

Insulin Biotech Dance Biopharma Withdraws $75 Million IPO

Astellas Pharma Inc., CoMentis, Inc. Terminate Alzheimer's Agreement

Eli Lilly and Company To Shut Down One Puerto Rico Plant, 100 People Affected

InterMune, Inc. Wins FDA Approval For Lung Drug At Center Of Roche Deal

Cadila Healthcare Recalls Blood Pressure Drug In The U.S.

The Top Selling Biologic Drugs

Abbott Laboratories Created 400 New Jobs With New Facility In India

100 New Jobs On Horizon At

Stimulant Found In Unapproved Diet Supplements Could Cause Heart Attacks

Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev

Exercise May Be The Best Anti-Aging Pill, Columbia University Study

Tumors Might Grow Faster At Night, Weizmann Institute of Science Study

Another Diet Myth Debunked: Gradual Weight Loss No Better Than Rapid Weight Loss, University of Melbourne Study

Fish Oil Supplements Have Little Effect On Irregular Heartbeat, Montreal Heart Institute Study

New Evidence Linking Autism To Air Pollutants Discovered, Researcher Reveals

How Big Pharma Made Us Hypochondriacs

Ex-Merck & Co. Analyst Charged With Passing Merger Tips To Friend

Shire Plummets As AbbVie Reconsiders $55 Billion Takeover Bid

Atara Biotherapeutics Prices IPO Below The Range At $11 A Share

Roche Lucentis, Regeneron Eylea Continue To Battle It Out In Eye Market

Gilead Sciences, Inc. Nervous As Johnson & Johnson Looks To Remain Competitive In Hepatitis C Market

Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials

AstraZeneca PLC Strengthens Partnership With The University of Cambridge

Ranbaxy Laboratories To Pay $40 Million To Settle Texas Medicaid Pricing Litigation

Ex-Mayo Clinic Exec Accused Of Stealing Trade Secrets

Peanut Allergy Biotech DBV Technologies Sets Terms For $98 Million U.S. IPO

222


    Read more..